14
Participants
Start Date
August 2, 2022
Primary Completion Date
February 8, 2024
Study Completion Date
February 8, 2024
Nivolumab/rHuPH20
Specified dose on specified days
Nivolumab
Specified dose on specified days
Local Institution - 0038, Coffs Harbour
Local Institution - 0003, Wollongong
Local Institution - 0008, Bendigo
Local Institution - 0029, Ghent
Local Institution - 0016, Milan
Local Institution - 0002, Madrid
Local Institution - 0043, Madrid
Local Institution - 0044, Knoxville
Local Institution - 0005, Seville
Local Institution - 0030, Valencia
Local Institution - 0004, Fort Wayne
Local Institution - 0015, Napoli
Local Institution - 0034, Opole
Local Institution - 0036, Bydgoszcz
Local Institution - 0026, Barcelona
Local Institution - 0040, Leicester
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY